| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Inhibikase Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 108,176 | 30 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | 30 Jun 2025 | 1 | $0 | 4 | Director | 02 Jul 2025, 19:40 |
| IKT | Inhibikase Therapeutics, Inc. | 14 Feb 2025 | 1 | $0 | 4 | Director | 19 Feb 2025, 20:00 |
| IKT | Inhibikase Therapeutics, Inc. | 21 Jan 2025 | 5 | $0 | 4/A | Director | 19 Feb 2025, 20:06 |
| IKT | Inhibikase Therapeutics, Inc. | 03 Jan 2025 | 3 | $0 | 4 | Director | 07 Jan 2025, 18:38 |
| IKT | Inhibikase Therapeutics, Inc. | 16 Jul 2024 | 1 | $0 | 4 | Director | 18 Jul 2024, 17:20 |
| IKT | Inhibikase Therapeutics, Inc. | 30 Jun 2023 | 1 | $0 | 4 | Director | 05 Jul 2023, 21:18 |
| IKT | Inhibikase Therapeutics, Inc. | 24 Jun 2022 | 1 | $0 | 4 | Director | 28 Jun 2022, 21:00 |
| IKT | Inhibikase Therapeutics, Inc. | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 19:09 |